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Summary 
 
Staphylococcus (staph) is a genus of bacteria 
found almost everywhere including in the soil and 
on the skin of many animal species.  Staph species 
are responsible for a considerable number of 
diseases ranging from carbuncles, bacteremia, and 
endocarditis.  Treatment of these illnesses is 
becoming increasingly difficult due to developing 
resistance.  Genes thought to be responsible for 
the resistance of Staphylococcus species may have 
originated in the species S. scuiri, possibly an 
ancestral species, and later transferred to other 
species.  Horizontal transfer of resistance genes is 
possible due to the close evolutionary relationship 
of one species of staph to another.  The emergence 
of antibiotic resistant bacteria, such as some 
strains of staph, can be attributed to the increase in 
use of antibiotics. Recently, resistance to 
medicines such as vancomycin has manifested.  
Antibiotic resistance of staph can be attributed to 
the transfer of the genes mecA, pls, and more by 
transduction.  This creates large problems for the 
medical community as new treatments against 
antibiotic resistant strains must be engineered.  
 
Prevalence of Staphylococcus 
 
Staphylococcus (staph) is a genus of bacteria 
found almost everywhere including in the soil, and on 
the skin of many animal species.  Staphylococcus 
aureus is commonly found on skin and in nasal 
passages of humans (Darini et. al., 2004). It is 
widespread throughout the human community but 
strains acquired by individuals in hospitals are often 
highly pathogenic (Ewald 1994). Recent studies have 
shown that the overall isolation rate of Staphylococcus 
sciuri in hospital environments is 10.5% (Stepanovic et. 
al., 2005).  Invasive procedures in hospitals are 
generally accompanied with special precautions to 
prevent the transmission of this bacterium from one 
patient to another, however post-procedure infection 
cannot be avoided.    
Other species, such as S. intermedius, are 
commonly found in horses, pigeons, dogs and other 
animals (Cookson et. al., 2004).  In dogs, S. 
intermedius is recognized as common skin flora that 
can also cause invasive disease in humans.  The 
isolation rate of S. intermedius is 18.5% from canine 
inflicted wounds (Cookson et. al., 2004). 
Staphylococcus species are responsible for a variety of 
diseases ranging from carbuncles and food poisoning 
to bacteremia and endocarditis (Parkhill et. al., 2004).  
Furthermore, it can be responsible for infections of the 
breast, in new mothers, and impetigo (Ewald 1994).  
Staphylococcus can even be the source of life- 
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threatening Toxic Shock Syndrome (Bauman). Some 
strains can be resistant to antibiotics causing 
complications in treating the associated illnesses. 
 
Evolutionary Tree of Staph Species 
 
Studies have suggested that many species of 
Staphylococcus have only recently diverged from a 
common ancestor.  Comparative analyses have shown, 
for example, that S. intermedius closely resembles S. 
aureus and S. epidermidis genetically (Cookson et. al., 
2004).  Thus, the term intermedius.   (Fig. 1) 
Genes thought to be responsible for the 
resistance of staphylococci species may have 
originated in the species S. scuiri, possibly an ancestral 
species, and later transferred to other species (aureus, 
intermedius, and epidermidis) or vice-versa (Stepanovic 
et. al., 2005).  Transfer of resistance genes is possible 
due to the close evolutionary relationship of one 
species of staph to another.  Genetic similarities 
interfere with a bacterium’s ability to distinguish its own 
species from another species, which facilitates gene 
transfer. 
 
Mechanisms of Antimicrobial Activity 
 
There are several mechanisms by which 
antimicrobials can function against bacteria.  Each 
mechanism interferes with some vital process or 
structure of the cell.  These include interference of 
protein synthesis, nucleic acid synthesis, metabolic 
activity, cell membrane function, or cell wall synthesis 
(Krasner).  The first three mechanisms require the 
antimicrobial agent to enter the cell for success.  
Examples of these drugs include sulfa drugs, 
erythromycin, and polymyxin B.  These types of drugs 
work on mostly on gram-negative bacteria that do not 
have a thick layer of peptidoglycan.   
Staphylococci, though, are gram-positive and 
are coated with a very thick layer of peptidogylcan.  
Antibiotics, such as penicillin and cephalosporin-based 
medicines, target this type of bacteria by interfering with 
synthesis of the cell wall.  Their molecular structures 
contain beta-lactam rings that interfere with the 
enzymes responsible for cell wall construction 
(Krasner).   
Resistance to these antimircobials can exist 
naturally within a population or random variants may 
arise through genetic mutation.   
 
Antibiotic Resistance 
 
The emergence of antibiotic resistant 
bacteria, such as some strains of staph, can be 
attributed to the increase in humans’ use of antibiotics.  
For example, bacteria isolated from patients 65 years 
ago, before the introduction of antimicrobial agents, 
show almost no resistance to antibiotics (O’Brien 2002).  
As the use of antimicrobial agents becomes more 
frequent, the appearance of bacterial resistance 
becomes more common and more rapid. 
Resistance to an antibiotic can be attributed 
to differences in gene products on or in a cell to 
interfere with the mode of action of the antibiotic.  Such 
differences in the genome can arise through mutation  
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Figure 1. Evolutionary Tree of Staphylococcus species 
discussed in this paper.  Question marks indicate that this is not 
a complete tree and does not contain other species.  
 
or by gene transfer from other bacteria of the same or 
different species.     
Gene swapping is fairly regular in bacteria 
and genomic similarities allow for highly facilitated gene  
transfer since some species of bacteria can partake in 
gene transfer only within their own species (Bauman).  
Genomic similarities allow for this barrier to be 
circumvented.  This can be highly detrimental for the 
medical community as resistance to one antibiotic can 
develop in one species and be transferred to another.  
This is then perpetuated by the introduction of a new 
antibiotic for the first species, which develops new 
resistance and passing it to the next creating a 
revolving door for the engineering of antimicrobial 
agents. 
 
Emergence of Staph Resistance 
 
A study conducted in 1989 by Talan et al. 
showed that only 79% of S. intermedius isolates were 
susceptible to penicillin, one of the first known 
antibiotics.  Since then, many strains of staph have 
been identified as resistant to penicillin derivatives such 
as oxacillin and methicillin. (Cookson et. al., 2004).  
Resistance level of S. intermedius to oxacillin-based 
drugs is documented as 60 to 85%, meaning that 
higher dose levels of the drug are needed to eradicate 
the bacteria.  S. intermedius is also beginning to show 
signs of methicillin resistance. 
Methicillin resistant S.  aureus (MRSA) were 
first noted in 1961 in Europe only two years after the 
introduction of the drug (Dohar et. al., 2005).  At first, 
only 3% of isolates were MR. This number soon 
increased to 38%.  As it stands now, MR strains are still 
less common than methicillin susceptible (MS)  strains.  
Thus, resistance to antibiotics is more costly in 
competition between strains.  Furthermore, patients 
who developed MR strains have had increased 
exposure to broad-spectrum antibiotics. 
Of Staphylococcus scuiri isolates obtained 
from hospital sampling in 2002, 73% showed resistance 
to one or more types of antimicrobial agents (Stapnovic 
et. al., 2005; 62.5% were resistant to penicillin, 64.3% 
were resistant to oxacillin, 3.5% were resistant to 
tetracycline, and 4.3% were multiresistant, among 
others).   
Reports of vancomycin resistant 
staphylococci from Brazil surfaced in 2004 (Darini et. 
al., 2004) and of MRSA coexisting with vancomycin 
resistant enterococci in 2005 (Samore et. al., 2005).   
The emergence of these resistant strains is 
exemplar to the theory of evolutionary antibiotic 
resistance in infectious diseases. 
 
Source of Resistance in Staph 
 
The administration of antimicrobials for 
nontheraputic purposes is one proposed source of 
resistance in bacteria.  It has been shown to select for 
resistance in multiple strains of pathogenic bacteria 
coexisting in concentrated animal feeding operations 
(Schwab et. al., 2005) making food products a source 
of resistant bacteria for humans.   
Strains of Staphylococcus exhibiting 
resistance to beta-lactam antibiotics have a common 
resistance gene.  This gene has been identified in an 
evolutionary precursor to S. scuiri, and as a homolog of 
a resistance gene, vanA, found in other bacterial 
species (Parkhill et. al., 2004).  This gene, denoted as 
mecA, is involved in the normal process of cell wall 
synthesis and does not contribute to resistance in the 
wild.  However, overexpression of the gene is shown to 
increase antibiotic resistance (Cookson et. al., 2004).   
Isolates of resistant strains acquired in 
hospitals have much larger regions of this gene and 
tend to show more resistance to the antibiotics (Samore 
et. al., 2005).     
MecA, which codes for penicillin-binding 
protein 2A, works in conjunction with immune evasion 
genes, such as pls, to give Staph strains resistance.  
 
The mecA Gene 
 
A study conducted by Parkhill et al. (2004) 
showed that a genomic stretch in several strains of 
MRSA was absent in methicillin susceptible strains of 
Staph.  This stretch contains the mecA gene as well as 
other genes that have not been identified thus far.   
(Fig. 2) 
MecA, when active, increases resistance to 
beta-lactam antibiotics (Tomasz, 2005).  Tomasz and 
colleagues demonstrated that a mecA homolog from 
MR S. scuiri introduced into methicillin susceptible S. 
aureus generated MRSA.  They confirmed this result by 
documenting that elimination of the plasmid containing 
mecA, resulting in methicillin susceptible strains.  This 
shows that the transfer of resistance genes between 
species confers resistance.  This also supports the idea 
that a close evolutionary relationship between staph 
species leads to increased ability to transfer genes. 
   
 
 
Figure 2. Genetic Comparison between MRSA (left) and MSSA 
taken from Parkhill et al. 2004.  (mecA is located on the outer 
ring at the top) 
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Additionally, when MR strains of 
staphylococci are stored for long periods of time, they 
lose the mecA gene and show signs of susceptibility to 
beta-lactam antibiotics (Kluytmans et. al., 2005). 
Tomasz et. al. (2001), also saw that, in 
conjunction with the mecA, staphylococci strains 
showed greater resistance to antimicrobials when 
penicillin-binding protein 2A (PBP2A) was expressed.  
He suggests that mecA codes for the expression the 
protein and overexpression of mecA leads to an 
increased production of PBP2A. 
 
Penicillin-Binding Protein 2A 
 
PBP2A is implicated in the production of the 
peptidoglycan layer (Tomasz et. al., 2001).  The 
strategy of normal beta-lactam antibiotics is to acetylate 
the transpeptidase domain of normal PBPs thereby 
inhibiting cell wall synthesis.  MecA expression, 
nonetheless, leads to the assembly of PBP2A as well 
as normal PBP2.  PBP2A is an extra subunit of 
transpeptidase. PBP2 only is composed of both a 
transpeptidase and transglycolase subunit.  The 
production of PBP2A allows for the transpeptidation of 
the peptidoglycan layer, in the presence of antibiotics, 
to regain its normal funcion (Tomazs et. al., 2001).  The 
function of PBP2A in non-antimicrobial conditions is 
unknown. 
 
The pls Gene 
 
Resistance in Staphylococcus is 
characterized not only by the abnormal function of cell 
processes, but an abnormally low adherence rate to a 
host’s extracellular proteins (Kuusela et. al., 2001).  
This often gives a negative result when testing for 
MRSA.  By introducing a point mutation into the gene 
coding for pls, Kuusela et. al. (2001), illustrated that pls 
is responsible for negative test results.  The idea that 
pls prevents adhesion of resistant staph to cell is highly 
favored.  Previoius studies  showed that susceptible 
staph strains do not code or express the pls gene or its 
protein. 
 Pls is found in the same regional DNA 
fragment as mecA.  Homologs of the pls gene are 
found in other species of antibiotic resistant bacteria, 
including multiple species of resistant staph.  This 
indicates that the species of bacteria that first 
developed novel mecA genes and swapped them with  
 
Table 1.  Species exhibiting resistance to antibiotics and the 
corresponding genes. 
 
another species also transferred natural or mutated pls 
genes.   
 
Different Resistance, Different Genes 
 
Resistance to other antibiotics, such as 
tetracycline and vancomycin, has been documented in 
various species of Staphylococcus  (Schwarz et. al., 
2006).  S. lentus, for example, has some strains which 
exhibit tetracycline resistance.  This resistance is 
caused, at least in part, by the plasmid pSTE2 (Table 
1).  Sequencing of the plasmid has shown that it has 
similarities to other known resistance plasmids.  Given 
what is already known about evolutionary antibiotic 
resistance, this plasmid, along with others, can be 
transferred easily to other species of bacteria leading to 
an allover increased resistance level.   
 
Acquisition of Resistance 
 
A study conducted by van Strijp and 
colleagues (2005) describes two newly discovered 
immune modulators: chemotaxis inhibitory protein of 
Staphylococcus aureus (CHIPS) and staphylococcal 
complement inhibitor (SCIN).  These genes also carry 
genes for immune evasion molecules.  They showed 
that 90% of S. aureus carry these genes, or variants of 
them, in the same stretches of DNA in the genome.  All 
forms of these genes have some effect on the human 
immune system.    
Furthermore, van Strijp demonstrated that β-
hemolysin converting bacteriophages transfer these 
genes from one microbe to another.   
Given that these genes are easily transferred 
via bacteriophage, it is possible that transduction is the 
method of resistance gene transfer among 
staphylococcal species.  Whether or not the virus 
responsible for resistance in staph is able to infect other 
species, it may play a role in the number of resistance 
genes transferred and which bacteria they come from.   
 
Precautionary Steps 
 
Common Sense 
 
One way to combat the spread of antibiotic 
resistant bacteria is simply the exercise of common 
knowledge such as washing your hands before you 
touch a patient in the hospital or hand washing between 
patients by staff.  For example, of the staph isolates in 
Stepanovic’s study (2005), none were found on the 
hands of medical personnel.  The reason was that all 
doctors and nurses at all medical institutions are 
required to wash their hands between patients; a 
practice started in 1848 by Ignaz Semmelweis who 
eventually got fired for implementing the routine even 
though the rate of post-procedure infection declined 
dramatically (Bauman). 
A second exercise of common knowledge is 
one that most people have been hearing for years: 
elimination of the overuse of antibiotics.  The hog 
farming industry uses 10.3 million pounds of antibiotics 
regularly and have been found to produce high-level 
drug resistance in staph species as well as other 
bacteria species (Schwab et. a., 2005).  Without the 
presence of antimicrobials in the environment, there 
would be no selection for antibiotic resistance. Lacking 
EyrthromyciermC werneri 
Vancomycin blaZ haemolytic
Penicillins, 
tetracylines 
mecA sciuri 
Tetracycline pSTE2 lentus 
Penicillins, 
vancomycin 
mecA, pls aureus 
Antibiotic Genes Species 
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this pressure for selection, on staph strains harboring 
resistance genes, the bacteria are likely to kick out the 
plasmid (Kluytmans).   
 
Natural Remedies 
 
 Due to the rapid development of resistance in 
bacteria to all antibiotics, synthetic or not, other 
alternatives must be found.  A study conducted by 
Molan et al. (2005) examines the antibacterial activity of 
honey against Staphylococcus.  They found that a 
concentration of 2.7-5% inhibited the growth of 18 staph 
isolates with no significant differences between honey 
type, antibiotic resistant vs. antibiotic susceptible, or 
species.  Furthermore, Molan showed that the inhibitory 
effect of natural honey as opposed to simulated honey 
was 5.5-11.7 times greater and that it could be diluted 
20 fold without losing its ability to behave as an 
antimicrobial.  They speculate that this activity is due to 
the enzymic production of hydrogen peroxide or some 
other phytochemical element. 
A second option is to use a compound not 
based on existing antibiotics.  Plant extracts can be one 
source of these.  S. aureus shows susceptibility to 
plants used in Columbian folkloric medicinal practices 
(Munoz et. al., 2006).  These plants include Bixa 
orellana, Gliricidia sepium, Jacaranda mimosifolia, and 
Piper pulchrum.    Such plants are used to treat a 
number of illnesses from gingivitis to bronchitis to 
infected wounds.  Extracts from this flora taken using 
distilled water, ethanol, and hexane all exhibited 
antimicrobial activity against S. aureus as well as other 
species of bacteria.  By creating new treatments from 
these plants, the likelihood of previously acquired 
resistance is lower.   
 
“Artificial” Fixes 
 
 One quick fix used to surmount the antibiotic 
resistance in bacterial species is to develop new 
antibiotics.  For example, new cephalosporin antibiotics 
interfere with the actions of PBP2A, consequently 
inhibiting cell wall synthesis in MRSA (Mobashery et. 
al., 2006).  Cephalosporins facilitate a conformational 
change in the active site of PBP2A.  This change 
decreases the affinity for the protein to help piece 
together segments of the cell wall.  As a result, osmotic 
pressure on the cell causes it to collapse and die.   
However, this is not the best method of 
controlling antibiotic resistance in light of the ability of 
bacteria to rapidly develop resistance.  Often, new 
antibiotics are based off of existing antimicrobials for 
which bacteria may already exhibit resistance.  It is 
likely that many new developments would not be viable 
methods of treatment for a considerable amount of 
time. 
  Nevertheless, this process can be deterred 
with the advancement of detection methods.  Given that 
many strains of staph have developed resistance, it is 
suggested that all patient samples should be 
immediately tested for penicillin, oxacillin, and 
vancomycin resistance.  The problem comes with 
results from phenotypic assays, such as disk diffusion, 
which take at least 24-48 hours to incubate (Appelbaum 
et. al., 2006).  Microassays, such as PCR and gene 
probing, have been shown to give accurate detection 
rates in S. aureus and S. epidermidis (Unai et. al., 
2005) for the mecA gene.  Rapid detection can reduce 
administration of unnecessary or incorrect antibiotics, 
which will lower the exposure of the bacteria and 
decrease the probability of resistance acquisition. 
Scientists have recently begun studying the 
use of bacteriophages in the reduction of the spread of 
resistant Staphylococcus strains (O’Flaherty et. al., 
2005).  Phage K, one such virus, affects nine different 
species of Staphylococcus including S. aureus and S. 
epidermidis. In the case of newly emerged resistant 
strains, 39 of the 53 strains tested showed sensitivity to 
unmodified Phage K and the other 14 were sensitive to 
modified Phage K.  Phage K infects the bacteria and 
ultimately causes death. It is important to note that a 
Phage K wash reduces staphylococcal cells on the skin 
but does not completely eliminate the bacteria, which 
leads one to believe that it may be possible to develop 
some resistance.  The effects of Phage K in vitro have 
not been established. 
 
Conclusion 
 
Emerging antibiotic resistance can be the 
product of close evolutionary relationships between 
bacterial species and the administration of antimicrobial 
agents.  Isolates collected before the use of antibiotics 
harbor no resistance genes (O’brien 2002).  Many 
strains of Staphylococcus show not only resistance but 
also mulit-drug resistance.  Evolutionary ties between 
species add complication to this task.  Many bacterial 
species can transfer genes within a species; close ties 
between two species may stop them from recognizing 
their differences and allow transfer.  In some cases, 
such as that of staph, the host range of a bacteriophage 
may play a part in gene transfer between closely tied 
species.   
Close monitoring of the use of antibiotics 
through diagnostics can aid in combating resistance.  
This will aid in reducing unnecessary exposure of 
bacteria to antimicrobials.  Reduced exposure can 
decrease the acquisition of resistance genes.   Newly 
discovered natural treatments, such as the use of plant 
extracts and honey, in conjunction with the use of 
engineered bacteriophages, Phage K, can also 
discourage these developments.  
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